Sale!

Urispas (Flavoxate Hcl)

A$0.00

-17%
Urispas (Flavoxate Hcl) is a medicine used to relieve symptoms of bladder problems, such as frequent urination, urgency, pain, or discomfort. It works by relaxing the muscles of the bladder, helping to reduce spasms and improve bladder control. Urispas is usually prescribed for conditions like overactive bladder or bladder irritation. Always follow your doctor’s instructions and let them know if you experience any side effects.

Urispas (Flavoxate Hydrochloride) – Patient Information for Australia

Basic Product Information

Active Ingredient (INN): Flavoxate Hydrochloride
Australia Brand Names: Urispas®
ATC Code: G04BD02
Available Forms & Strengths: Tablets: 200 mg Flavoxate HCl
Manufacturers: Paladin Labs Australia Pty Ltd, Mylan Health Pty Ltd
Prescription Status: Prescription Only (Schedule 4, S4)

Mechanism of Action

For Everyone: Urispas works by relaxing the muscles of the bladder and urinary tract, helping to reduce muscle spasms, urgency, and discomfort when passing urine.
For Healthcare Professionals: Flavoxate is a smooth muscle relaxant with anticholinergic properties, acting primarily at the detrusor muscle. It inhibits phosphodiesterase, thereby increasing cyclic AMP in smooth muscle cells and reducing involuntary contractions of the detrusor and related urinary tract musculature.

Pharmacokinetics

  • Absorption: Rapidly absorbed after oral administration, reaching peak levels in 1–2 hours.
  • Metabolism: Extensively metabolised in the liver.
  • Elimination: Excreted mainly via the kidneys, mostly in metabolised form.
  • Duration of Action: Symptomatic benefit typically lasts 6–8 hours per dose.

Use in Everyday Life and Best Practices in Australia

Urispas is commonly prescribed to relieve painful urination, urgency, and frequent urination associated with bladder and urinary tract problems, including cystitis, prostatitis, and other irritative conditions. It is typically used alongside other treatments, as recommended by your GP or urologist. For most adults, the usual dose is one 200 mg tablet taken three or four times a day. Follow your healthcare provider’s instructions closely. Take each tablet whole with a glass of water. Urispas tablets can be fitted conveniently into everyday routines, with dosing times spread throughout waking hours for the best effect. It is important for Australian patients to maintain hydration, especially in hot climates and when physically active.

Dosing in the Morning versus Evening

  • Morning Dosing: Starting the first dose in the morning helps reduce symptoms during the day when urinary irritation can be worst.
  • Evening Dosing: Taking a dose before bed may lessen nocturia (night-time urination), although taking Urispas too late in the evening may not always be necessary for all patients.
  • Regularity Tips: Try to take the tablet at around the same times each day for the most reliable symptom control.

Taking with Food or on an Empty Stomach

Urispas may be taken with or without food. Taking it with meals can help reduce the chance of mild stomach upset, but it is generally well tolerated on an empty stomach. In Australian dietary context—where meals are commonly substantial and may include fibre, dairy, and lean proteins—there is no special restriction needed. Avoid excessive caffeine or spicy foods, as they may aggravate bladder symptoms.

Interaction Warnings

Interaction Advice
Other Anticholinergics May increase risk of dry mouth, constipation, blurred vision.
Alcohol May increase drowsiness and risk of side effects. Limit or avoid.
CNS Depressants (sedatives, sleeping pills) Increased risk of drowsiness or confusion, especially in elderly.
Certain Antibiotics No direct interactions, but always inform your doctor of all medicines being used.
Food No significant interactions. Take with/without food as tolerated.
Grapefruit Juice No known interactions.
Herbal Supplements Check with your pharmacist or doctor.

Indications

Indication Status
Symptomatic relief of urinary tract muscle spasm (cystitis, urethritis, prostatitis) Approved (TGA)
Nervous or dysuria from underlying bladder disorder Approved
Overactive bladder (OAB) symptoms Off-label
Paediatric lower urinary tract dysfunction Off-label (specialist guidance required)

Dosing According to Clinical Indications

Population/Indication Recommended Dose
Adults 200 mg tablet, 3–4 times daily (max 800 mg/day)
Children (over 12 years) 200 mg tablet, 2–3 times daily (specialist only)
Elderly Start at lowest effective dose
Hepatic/Renal Impairment Caution and dose adjustment may be required; specialist advice.

Safety Profile – Side Effects

Common side effects:
  • Dry mouth
  • Drowsiness
  • Blurred vision
  • Mild stomach upset or nausea
  • Headache
  • Dizziness
Rare side effects:
  • Rapid heart rate
  • Confusion, especially in elderly
  • Hypersensitivity reactions (rash, itching, swelling)
  • Urinary retention
Warnings: Seek immediate medical attention for difficulty breathing, chest pain, or severe allergic reaction.

Guidelines for Proper Use – Advice from Australian Pharmacists and Clinics

  • Take as prescribed and do not exceed the recommended daily amount.
  • If you miss a dose, take it as soon as you remember, unless it’s almost time for your next dose—then skip the missed dose.
  • Store at room temperature, away from sunlight and moisture.
  • Keep out of reach of children and pets.
  • Report any new or unusual symptoms to your doctor or pharmacist promptly.
  • Inform surgeons, anaesthetists, or dentists you are taking Urispas before procedures.
  • Regular reviews with your GP are advisable, especially for ongoing symptoms or if you are elderly.

Alternative Treatment Options (PBS Reimbursed where relevant)

Medicine ATC Code Pros Cons PBS Listing
Oxybutynin G04BD04 Well-studied; available as tablets, patches More anticholinergic side effects, dry mouth Yes
Solifenacin G04BD08 Once-daily dosing Constipation, dry mouth, higher cost Yes
Mirabegron G04BD12 Differing side effect profile; less dry mouth May raise blood pressure, cost Yes
Non-pharmaceutical (bladder training, pelvic physiotherapy) N/A No medicine side effects Takes time, requires effort N/A

Legal, Registration, and Reimbursement Status in Australia

  • Registered with the Therapeutic Goods Administration (TGA) for the treatment of lower urinary tract muscle spasms.
  • Prescription Only (Schedule 4/S4): Urispas is not available over-the-counter.
  • As of 2024, Urispas is not listed on the Pharmaceutical Benefits Scheme (PBS), meaning patients pay full cost unless covered under specific hospital arrangements.
  • Dispensed at community or hospital pharmacies upon presentation of a valid prescription from a GP or urologist.
  • No special authority is required for use in approved indications.

Latest Research and Clinical Guidance (2022–2025)

  • Recent studies published in BJU International (2023) and Australian Prescriber (2023–24) confirm the role of flavoxate as a safe symptomatic treatment but highlight limited evidence for underlying bladder disease management compared to first-line agents like oxybutynin and mirabegron.
  • Australian and UK clinical guidelines recommend considering Urispas where anticholinergic burden is acceptable, particularly for short-term symptom relief.
  • Research stresses careful dosing in elderly patients and preference for non-pharmaceutical therapies where possible to reduce polypharmacy risks.

References:
- "Treatment of Overactive Bladder Syndrome in Adults," BJU International, 2023.
- Martini et al., "Pharmacological Management of Lower Urinary Tract Symptoms," Australian Prescriber, 2024.

Availability and Delivery – Pack Sizes, Price, and Shipping Times in Australia

Pack Size Indicative PBS Price* Private Price (AUD) Delivery Time – Sydney Delivery Time – Melbourne Delivery Time – Brisbane
30 tablets (200 mg) Not PBS listed $24–$32 1–2 days 1–2 days 1–2 days
90 tablets (200 mg) Not PBS listed $65–$90 2–3 days 2–3 days 2–3 days
*PBS price as of May 2024. Delivery times may vary.

Frequently Asked Questions (FAQ)

1. Is Urispas (Flavoxate) safe for use in pregnancy or breastfeeding?
The safety of flavoxate in pregnancy or breastfeeding is not firmly established. Always consult your GP or obstetrician. It is not routinely recommended without medical advice.

2. Can I drive or use machinery while taking Urispas?
Urispas may cause drowsiness or blurred vision in some people. Avoid driving or operating heavy machinery until you know how it affects you.

3. What should I do if I miss a dose?
If you miss a dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose—do not double up.

4. How long can I take Urispas for my symptoms?
Use as directed by your doctor, usually for the shortest possible period to control symptoms. Chronic or long-term use should be regularly reviewed by your GP.

5. Can Urispas cure my bladder problem?
Urispas helps control symptoms but does not treat the underlying cause. Your doctor may also recommend tests, lifestyle changes, or other medication.

Additional information

Dosage: No selection

200mg

Package: No selection

30 pill, 60 pill, 90 pill, 120 pill, 180 pill